Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

ALDH2

Identity

HGNC ALDH2
Location 12q24.2
Location_base_pair Starts at 110688729 and ends at 110732167 bp from pter ( according to hg18-Mar_2006).

DNA/RNA

Description ALDH2 gene spans 46031 base pairs (bp), consists of 13 exons and 12 introns and is located on the (+) DNA strand.
Transcription The ALDH2 mRNA consists of 1989 base

Protein

Description The ALDH2 protein is 517 amino acid long, has a molecular weight of 56 Kd, and forms a homotetramer.
Expression ALDH2 is expressed in several human tissues with the highest levels found in liver. Screening of human cDNA libraries has revealed that ALDH2 transcripts are present in human liver, kidney, heart, stomach, colon, muscle, ovary, pancreas, lung, prostate, ear, eye, marrow, gall bladder, testis, thyroid, retina, adipose, adrenal gland, blood, brain, breast, placenta, uterus, B-cells, fetal brain, tonsil, foreskin, nervous normal and also in lung tumor, bladder tumor, nervous tumor.
Localisation Mitochondrial matrix
Function Conversion of aldehydes to acids via the reaction: ALDEHYDE + NAD + H2O = ACID + NADH
Homology ALDH2 belongs to the aldehyde dehydrogenase gene superfamily .

Mutations

Germinal One of the most studied polymorphism is a single base-pair mutation (1510 GÆA) in exon 12 of ALDH2 gene that causes an E487K substitution (ALDH2*2 allele), which results in catalytic inactivation of the enzyme. The ALDH2*2 allele is dominant negative and is responsible for acute alcohol intoxication due to accumulation of acetaldehyde. Facial flushing, nausea, dizziness and tachycardia characterize this alcohol intoxication. The ALDH2*2 allele is frequent in, but confined to Asian individuals, and it appears to be a determinant against alcoholism. On the other hand, alcohol-drinking individuals having the ALDH2*2 genotype are at substantially high risk of developing esophageal and upper aerodigestive tract cancers, head and neck cancers, colorectal cancer.

Implicated in

Entity Uterine leiomyoma (uterine fibroids) --> HMGIC-ALDH2
Disease Benign mesenchymal tumors
Prognosis Good
Hybrid/Mutated Gene The HMGIC-ALDH2 aberrant transcript contains complete exons 1-3 of HMGI-C and the epitopic sequence that includes complete exon 13 of the ALDH2 gene and part of the 3' untrasnlated region of this gene.
Abnormal Protein The ALDH2 contributes 10 amino acids to the fusion HMGIC-ALDH2 protein.
Oncogenesis HMGIC-ALDH2: it has been suggested that the truncation of HMGIC, rather than fusion may be responsible for tumorigenesis. The fusion of the 3' untranslated region of the ALDH2 may contribute to the stabilization of HMGIC mRNA.
  

External links

Nomenclature
HGNCALDH2   404
Entrez_GeneALDH2  217  aldehyde dehydrogenase 2 family (mitochondrial)
Cards
AtlasALDH2ID250
GeneCardsALDH2
EnsemblENSG00000111275 [Gene_View]  ALDH2 [Vega]
GenatlasALDH2
Genomic and cartography
GoldenPathALDH2  -  12q24.2   chr12:110688729-110732167 +  12q24.12   [Description]    (hg18-Mar_2006)
EnsemblALDH2 - 12q24.12 [CytoView]
NCBIMapview
OMIM100650 Disease map [OMIM]
HomoloGeneALDH2
Gene and transcription
GenbankAK223373 [ ENTREZ ]
GenbankAK301375 [ ENTREZ ]
GenbankAK314856 [ ENTREZ ]
GenbankAY621070 [ ENTREZ ]
GenbankBC002967 [ ENTREZ ]
RefSeqNM_000690 [ SRS ]    NM_000690 [ ENTREZ ]
RefSeqAC_000055 [ SRS ]    AC_000055 [ ENTREZ ]
RefSeqAC_000144 [ SRS ]    AC_000144 [ ENTREZ ]
RefSeqNC_000012 [ SRS ]    NC_000012 [ ENTREZ ]
RefSeqNT_009775 [ SRS ]    NT_009775 [ ENTREZ ]
RefSeqNW_001838063 [ SRS ]    NW_001838063 [ ENTREZ ]
RefSeqNW_925395 [ SRS ]    NW_925395 [ ENTREZ ]
CCDSALDH2 CCDS - NCBI
AceViewALDH2 AceView - NCBI
UnigeneHs.632733 [ SRS ]    Hs.632733 [ NCBI ]
Fast-db13453 (alternative variants)
Protein : pattern, domain, 3D structure
SwissProtP05091 [ SRS]    P05091 [ EXPASY ]     P05091 [ INTERPRO ]     P05091 [ UNIPROT ] P05091 [ VarSplice FASTA ]
PrositePS00070 ALDEHYDE_DEHYDR_CYS [ SRS ]    PS00070 ALDEHYDE_DEHYDR_CYS [ Expasy ]
PrositePS00687 ALDEHYDE_DEHYDR_GLU [ SRS ]    PS00687 ALDEHYDE_DEHYDR_GLU [ Expasy ]
InterproIPR016160 Ald_DHase_CS [ SRS ]    IPR016160 Ald_DHase_CS [ EBI ]
InterproIPR016162 Ald_DHase_N [ SRS ]    IPR016162 Ald_DHase_N [ EBI ]
InterproIPR015590 Aldehyde_DHase [ SRS ]    IPR015590 Aldehyde_DHase [ EBI ]
CluSTrP05091
PfamPF00171 Aldedh [ SRS ]    PF00171 Aldedh [ Sanger ]    pfam00171 [ NCBI-CDD ]
BlocksP05091
PDB1CW3 [ SRS ]    1CW3 [ PdbSum ],   1CW3 [ IMB ]   1CW3 [ RSDB ]
PDB1NZW [ SRS ]    1NZW [ PdbSum ],   1NZW [ IMB ]   1NZW [ RSDB ]
PDB1NZX [ SRS ]    1NZX [ PdbSum ],   1NZX [ IMB ]   1NZX [ RSDB ]
PDB1NZZ [ SRS ]    1NZZ [ PdbSum ],   1NZZ [ IMB ]   1NZZ [ RSDB ]
PDB1O00 [ SRS ]    1O00 [ PdbSum ],   1O00 [ IMB ]   1O00 [ RSDB ]
PDB1O01 [ SRS ]    1O01 [ PdbSum ],   1O01 [ IMB ]   1O01 [ RSDB ]
PDB1O02 [ SRS ]    1O02 [ PdbSum ],   1O02 [ IMB ]   1O02 [ RSDB ]
PDB1O04 [ SRS ]    1O04 [ PdbSum ],   1O04 [ IMB ]   1O04 [ RSDB ]
PDB1O05 [ SRS ]    1O05 [ PdbSum ],   1O05 [ IMB ]   1O05 [ RSDB ]
PDB1OF7 [ SRS ]    1OF7 [ PdbSum ],   1OF7 [ IMB ]   1OF7 [ RSDB ]
PDB1ZUM [ SRS ]    1ZUM [ PdbSum ],   1ZUM [ IMB ]   1ZUM [ RSDB ]
PDB2ONM [ SRS ]    2ONM [ PdbSum ],   2ONM [ IMB ]   2ONM [ RSDB ]
PDB2ONN [ SRS ]    2ONN [ PdbSum ],   2ONN [ IMB ]   2ONN [ RSDB ]
PDB2ONO [ SRS ]    2ONO [ PdbSum ],   2ONO [ IMB ]   2ONO [ RSDB ]
PDB2ONP [ SRS ]    2ONP [ PdbSum ],   2ONP [ IMB ]   2ONP [ RSDB ]
HPRD00003
Protein Interaction databases
DIPP05091
IntActP05091
Polymorphism : SNP, mutations, diseases
OMIM100650    [ map ]   
GENETests100650
SNPALDH2 [dbSNP-NCBI]  
SNPNM_000690 [SNP-NCI]  
SNPALDH2 [GeneSNPs - Utah]  ALDH2] [HGBASE - SRS]
HAPMAPALDH2 [HAPMAP]  
COSMICALDH2 [Somatic mutation (COSMIC-CGP-Sanger)]  
HGMDALDH2
Genetic AssociationALDH2
CDC HuGEALDH2
General knowledge
Family BrowserALDH2 [UCSC Family Browser]
SOURCENM_000690
SMDHs.632733
SAGEHs.632733
Enzyme1.2.1.3 [ Enzyme-Expasy ]   1.2.1.3 [ Enzyme-SRS ]   1.2.1.3 [ IntEnz-EBI ]   1.2.1.3 [ BRENDA ]   1.2.1.3 [ KEGG ]   
GOaldehyde dehydrogenase (NAD) activity [Amigo]  aldehyde dehydrogenase (NAD) activity
GOaldehyde dehydrogenase [NAD(P)+] activity [Amigo]  aldehyde dehydrogenase [NAD(P)+] activity
GOneuropeptide hormone activity [Amigo]  neuropeptide hormone activity
GOmitochondrion [Amigo]  mitochondrion
GOmitochondrial matrix [Amigo]  mitochondrial matrix
GOcarbohydrate metabolic process [Amigo]  carbohydrate metabolic process
GOalcohol metabolic process [Amigo]  alcohol metabolic process
GOneuropeptide signaling pathway [Amigo]  neuropeptide signaling pathway
GOelectron carrier activity [Amigo]  electron carrier activity
GOoxidoreductase activity [Amigo]  oxidoreductase activity
GOoxidation reduction [Amigo]  oxidation reduction
KEGGGlycolysis / Gluconeogenesis
KEGGAscorbate and aldarate metabolism
KEGGFatty acid metabolism
KEGGBile acid biosynthesis
KEGGValine, leucine and isoleucine degradation
KEGGLysine degradation
KEGGArginine and proline metabolism
KEGGHistidine metabolism
KEGGTryptophan metabolism
KEGGbeta-Alanine metabolism
KEGGGlycerolipid metabolism
KEGGPyruvate metabolism
KEGGPropanoate metabolism
KEGGButanoate metabolism
KEGGLimonene and pinene degradation
PubGeneALDH2
TreeFamALDH2
CTD217 [Comparative ToxicoGenomics Database]
Other databases
Probes
ProbeCancer Cytogenetics (Bari)
ProbeALDH2 Related clones (RZPD - Berlin)
PubMed
PubMed231 Pubmed reference(s) in Entrez

Bibliography

Molecular abnormality and cDNA cloning of human aldehyde dehydrogenases.
Yoshida A, Ikawa M, Hsu LC, Tani K
Alcohol (Fayetteville, N.Y.). 1985 ; 2 (1) : 103-106.
PMID 4015823
 
Description of a novel fusion transcript between HMGI-C, a gene encoding for a member of the high mobility group proteins, and the mitochondrial aldehyde dehydrogenase gene.
Kazmierczak B, Hennig Y, Wanschura S, Rogalla P, Bartnitzke S, Van de Ven W, Bullerdiek J
Cancer research. 1995 ; 55 (24) : 6038-6039.
PMID 8521389
 
Investigation of genetic risk factors associated with alcoholism.
Harada S, Okubo T, Tsutsumi M, Takase S, Muramatsu T
Alcoholism, clinical and experimental research. 1996 ; 20 (9 Suppl) : 293A-296A.
PMID 8986225
 
Description of a novel fusion transcript between HMGI-C, a gene encoding for a member of the high mobility group proteins, and the mitochondrial aldehyde dehydrogenase gene.
Kazmierczak B, Hennig Y, Wanschura S, Rogalla P, Bartnitzke S, Van de Ven W, Bullerdiek J
Cancer research. 1995 ; 55 (24) : 6038-6039.
PMID 8521389
 
Effects of worldwide population subdivision on ALDH2 linkage disequilibrium.
Peterson RJ, Goldman D, Long JC
Genome research. 1999 ; 9 (9) : 844-852.
PMID 10508843
 
Genotype difference of aldehyde dehydrogenase 2 gene in alcohol drinkers influences the incidence of Japanese colorectal cancer patients.
Murata M, Tagawa M, Watanabe S, Kimura H, Takeshita T, Morimoto K
Japanese journal of cancer research : Gann. 1999 ; 90 (7) : 711-719.
PMID 10470282
 
Association of aldehyde dehydrogenase 2 gene polymorphism with multiple oesophageal dysplasia in head and neck cancer patients.
Muto M, Hitomi Y, Ohtsu A, Ebihara S, Yoshida S, Esumi H
Gut. 2000 ; 47 (2) : 256-261.
PMID 10896918
 
Polymorphisms of human aldehyde dehydrogenases. Consequences for drug metabolism and disease.
Vasiliou V, Pappa A
Pharmacology. 2000 ; 61 (3) : 192-198.
PMID 10971205
 
REVIEW articlesautomatic search in PubMed
Last year publicationsautomatic search in PubMed

Search in all EBI   NCBI

Contributor(s)

Written09-2001Vasilis Vasiliou, Nickolas Sophos
Molecular Toxicology University of Colorado Health Sciences Center (UCHSC) Dept. of Pharmaceutical Sciences, C-238 4200 East Ninth Avenue Denver, CO 80262, USA

Citation

This paper should be referenced as such :
Vasiliou V, Sophos N . ALDH2. Atlas Genet Cytogenet Oncol Haematol. September 2001 .
URL : http://AtlasGeneticsOncology.org/Genes/ALDH2ID250.html

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Thu Nov 27 13:19:20 2008


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us

jlhuret@AtlasGeneticsOncology.org.